Tebuconazole

Overview

Tebuconazole is an orally active agricultural azole fungicide which can also inhibit CYP51 with IC 50 s of 0.9 and 1.3 μM for Candida albicans CYP51 ( CaCYP51 ) and truncated Homo sapiens CYP51 ( Δ60HsCYP51 ), respectively. Tebuconazole induces lipid accumulation and oxidative stress in HepG2 Cells. Tebuconazole decreases MAC-T cells viability and proliferation, induces ER-stress-mediated apoptosis and increases oxidative stress levels in MAC-T cells.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Fungal Infection | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Parkinson's Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Infection | Products > Signaling Pathways > Environmental Pollutants | Products > Signaling Pathways > Fungal | Products > Signaling Pathways > Cytochrome P450 | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-B0852
• CAS No.: 107534-96-3
• Molecular Formula: C16H22ClN3O
• Molecular Weight: 307.82
• Purity: 99.63%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (8.12 mM); Clear solution
• Availability: In-stock

Source

Original product source